BLT1: a promising therapeutic approach for atherosclerosis

Herz. 2016 Aug;41(5):441-2. doi: 10.1007/s00059-015-4388-y. Epub 2015 Dec 10.

Authors

P Zeng¹, J Yang²

Affiliations

¹ Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, 443000, Yichang, Hubei Province, China.
² Department of Cardiology, the First College of Clinical Medical Sciences, Institute of Cardiovascular Diseases, China Three Gorges University, Yiling Road 183, 443000, Yichang, Hubei Province, China. 898375964@qq.com.

PMID: 26659842
DOI: 10.1007/s00059-015-4388-y

No abstract available

Publication types

Review

MeSH terms

Atherosclerosis / drug therapy*
Atherosclerosis / metabolism*
Evidence-Based Medicine
Humans
Leukotriene B4 / administration & dosage*
Molecular Targeted Therapy / methods*
Receptors, Leukotriene B4 / antagonists & inhibitors*
Treatment Outcome

Substances

LTB4R protein, human
Receptors, Leukotriene B4
Leukotriene B4